Shagun Singh
Stock Analyst at RBC Capital
(2.54)
# 2,265
Out of 4,681 analysts
181
Total ratings
50.65%
Success rate
-0.07%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: Outperform | $75 → $80 | $70.53 | +13.43% | 19 | Nov 27, 2024 | |
| NVRO Nevro | Reiterates: Sector Perform | $7 | $4.27 | +63.93% | 9 | Nov 12, 2024 | |
| GMED Globus Medical | Maintains: Outperform | $80 → $92 | $83.90 | +9.65% | 5 | Nov 6, 2024 | |
| INSP Inspire Medical Systems | Reiterates: Outperform | $260 | $188.52 | +37.92% | 3 | Nov 5, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $120 → $125 | $110.50 | +13.12% | 12 | Nov 4, 2024 | |
| TFX Teleflex | Maintains: Outperform | $275 → $245 | $194.31 | +26.09% | 19 | Nov 1, 2024 | |
| SYK Stryker | Maintains: Outperform | $386 → $400 | $389.63 | +2.66% | 16 | Oct 30, 2024 | |
| DXCM DexCom | Maintains: Outperform | $120 → $115 | $79.31 | +45.00% | 4 | Oct 25, 2024 | |
| BSX Boston Scientific | Maintains: Outperform | $95 → $98 | $90.43 | +8.37% | 13 | Oct 24, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $525 → $555 | $542.85 | +2.24% | 13 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $154.80 | +16.93% | 15 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $98 → $105 | $86.54 | +21.33% | 19 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $11 | $8.22 | +33.82% | 5 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $205 → $222 | $244.84 | -9.33% | 10 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $130 | $116.81 | +11.29% | 10 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $65 | $32.51 | +99.94% | 1 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $6 → $3 | $0.91 | +231.46% | 8 | Aug 8, 2024 |
Edwards Lifesciences
Nov 27, 2024
Maintains: Outperform
Price Target: $75 → $80
Current: $70.53
Upside: +13.43%
Nevro
Nov 12, 2024
Reiterates: Sector Perform
Price Target: $7
Current: $4.27
Upside: +63.93%
Globus Medical
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $92
Current: $83.90
Upside: +9.65%
Inspire Medical Systems
Nov 5, 2024
Reiterates: Outperform
Price Target: $260
Current: $188.52
Upside: +37.92%
Zimmer Biomet Holdings
Nov 4, 2024
Maintains: Outperform
Price Target: $120 → $125
Current: $110.50
Upside: +13.12%
Teleflex
Nov 1, 2024
Maintains: Outperform
Price Target: $275 → $245
Current: $194.31
Upside: +26.09%
Stryker
Oct 30, 2024
Maintains: Outperform
Price Target: $386 → $400
Current: $389.63
Upside: +2.66%
DexCom
Oct 25, 2024
Maintains: Outperform
Price Target: $120 → $115
Current: $79.31
Upside: +45.00%
Boston Scientific
Oct 24, 2024
Maintains: Outperform
Price Target: $95 → $98
Current: $90.43
Upside: +8.37%
Intuitive Surgical
Oct 18, 2024
Maintains: Outperform
Price Target: $525 → $555
Current: $542.85
Upside: +2.24%
Oct 16, 2024
Maintains: Outperform
Price Target: $178 → $181
Current: $154.80
Upside: +16.93%
Oct 10, 2024
Upgrades: Outperform
Price Target: $98 → $105
Current: $86.54
Upside: +21.33%
Oct 8, 2024
Maintains: Outperform
Price Target: $12 → $11
Current: $8.22
Upside: +33.82%
Oct 8, 2024
Maintains: Outperform
Price Target: $205 → $222
Current: $244.84
Upside: -9.33%
Oct 8, 2024
Maintains: Outperform
Price Target: $125 → $130
Current: $116.81
Upside: +11.29%
Oct 2, 2024
Initiates: Outperform
Price Target: $65
Current: $32.51
Upside: +99.94%
Aug 8, 2024
Downgrades: Sector Perform
Price Target: $6 → $3
Current: $0.91
Upside: +231.46%